RecruitingPhase not listedNCT07676565
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
Sponsor: Indiana University
New York, NY · Rochester, NY · +14 more sites
Type 1 Diabetes clinical trials in New York, NY
21 recruiting type 1 diabetes studies with a site in New York, NY.
RecruitingPhase 3NCT07088068
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Sponsor: Sanofi
Buffalo, NY · New York, NY · +31 more sites
RecruitingNot applicableNCT07282639
App-Based Certified Diabetes Education Therapy (AB-CDE)
Sponsor: Oregon Health and Science University
New York, NY · +5 more sites
RecruitingPhase 1 / Phase 2NCT06783309
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Sponsor: COUR Pharmaceutical Development Company, Inc.
Buffalo, NY · New York, NY · +42 more sites
RecruitingPhase 2NCT07216391
Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
New York, NY · +5 more sites
RecruitingPhase 2NCT07142252
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
New York, NY · +13 more sites
RecruitingPhase 3NCT07797335
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Sponsor: Novo Nordisk A/S
Manlius, NY · New Windsor, NY · New York, NY · +106 more sites
RecruitingPhase not listedNCT06860516
HLA Demographics Study in Adults With Type 1 Diabetes
Sponsor: GentiBio, Inc
New York, NY · +4 more sites
RecruitingPhase not listedNCT07360080
Long-Term Outcomes of Teplizumab in Routine Clinical Care
Sponsor: Sanofi
New York, NY · Syosset, NY · +3 more sites
RecruitingNot applicableNCT07773779
APP-MNT: App-Enhanced Medical Nutrition Therapy on Glycemic Outcomes and Quality of Life
Sponsor: Weill Medical College of Cornell University
New York, NY
RecruitingPhase 1NCT06919354
A Study of GNTI-122 in Adults Recently Diagnosed With T1D
Sponsor: GentiBio, Inc
New York, NY · +8 more sites
RecruitingNot applicableNCT05899023
ED Diabetes Screening and Outpatient Care - Aim 3
Sponsor: NYU Langone Health
New York, NY
RecruitingPhase 2NCT05762107
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Sponsor: Zucara Therapeutics Inc.
Albany, NY · Long Island City, NY · New York, NY · +35 more sites
RecruitingPhase not listedNCT04334707
Kidney Precision Medicine Project
Sponsor: Icahn School of Medicine at Mount Sinai
New York, NY · +12 more sites
RecruitingPhase 4NCT05641753
Cholesterol Lowering and Residual Risk in Diabetes, Type 1
Sponsor: NYU Langone Health
New York, NY · +1 more sites
RecruitingPhase not listedNCT00097292
TrialNet Pathway to Prevention of T1D
Sponsor: University of South Florida
New York, NY · +16 more sites
RecruitingPhase not listedNCT06203106
NYSCF Scientific Discovery Biobank
Sponsor: New York Stem Cell Foundation Research Institute
New York, NY
RecruitingPhase 1 / Phase 2NCT05824975
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Sponsor: GI Innovation, Inc.
New York, NY · +4 more sites
RecruitingPhase not listedNCT06141434
PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life
Sponsor: University of Colorado, Denver
New York, NY · +3 more sites
Not yet recruitingPhase 2NCT07808151
Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
Sponsor: Solstice Oncology, Inc.
New York, NY · +8 more sites
Not yet recruitingNot applicableNCT07808385
Single Arm Intervention Trial of DEKA TWIIST TM Insulin Pump Utilizing Tidepool Loop Algorithm in Pregnant People With Pre-existing Type 1 Diabetes
Sponsor: Mayo Clinic
New York, NY · +3 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.